Pathology/Lab Coding Alert

Distinguish 'Unspecified' Vs.'Uncertain' Neoplasms -- Here's How

Don't let 238/239 confusion leave medical necessity to chance. You may feel "uncertain" when selecting a neoplasm code for a pathology report -- but that doesn't mean the lesion is uncertain. Mistaking "uncertain" for "unspecified" could cost you, based on payers' covered diagnosis lists that impact medical necessity decisions. Take a look at our experts' explanations and examples to make sure you know the difference. Know the Big Picture To understand the uncertain/unspecified distinction, you need to comprehend the overall neoplasm diagnostic classification scheme. The ICD-9 neoplasm table distinguishes cancers as malignant, benign, uncertain, or unspecified. Let's start with the malignant/benign difference, because that's the key to understanding the "uncertain" classification. "Malignant neoplasms are cancerous, and may be noninvasive (in situ), or invasive," explains R.M. Stainton Jr., MD, president of Doctors' Anatomic Pathology Services in Jonesboro, Ark. ICD-9 further subdivides invasive cancers as "primary," meaning that the cancer arises from surrounding [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more